We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Intercorp Financial Services
IFS
$6.05B
| $4.57M | 0.02% |
110,705
| – | – |
|
627
Moog Inc Class A
MOG.A
$11.4B
| $4.57M | 0.02% |
53,500
-5,400
| -9% | -$462K |
|
628
Rambus
RMBS
$8.83B
| $4.55M | 0.02% |
330,400
| – | – |
|
629
Tapestry
TPR
$23.5B
| $4.54M | 0.02% |
168,144
+154,445
| +1,127% | +$4.03M |
|
630
Assembly Biosciences
ASMB
$519M
| $4.53M | 0.02% |
18,455
-3,254
| -15% | -$599K |
|
631
Masco
MAS
$13.5B
| $4.51M | 0.02% |
94,045
-187,093
| -67% | -$8.51M |
|
632
Franco-Nevada
FNV
$50B
| $4.49M | 0.02% |
43,440
+401
| +0.9% | +$38.8K |
|
633
Coca-Cola Europacific Partners
CCEP
$45.3B
| $4.46M | 0.02% |
87,744
-126,300
| -59% | -$6.65M |
|
634
Infosys
INFY
$44.9B
| $4.45M | 0.02% |
431,023
+34,298
| +9% | +$345K |
|
635
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
| $4.42M | 0.02% |
48,405
-75,942
| -61% | -$6.92M |
|
636
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
| $4.41M | 0.02% |
34,450
+5,222
| +18% | +$665K |
|
637
Bank of Hawaii
BOH
$2.95B
| $4.38M | 0.02% |
46,000
-8,566
| -16% | -$762K |
|
|
WDR
638
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.37M | 0.02% |
261,200
| – | – |
|
|
FOMX
639
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.34M | 0.02% |
1,304,424
| – | – |
|
|
DEA
640
Easterly Government Properties
DEA
$1.1B
| $4.33M | 0.02% |
72,939
-9,982
| -12% | -$563K |
|
641
Roku
ROKU
$23B
| $4.27M | 0.02% |
31,906
-6,594
| -17% | -$906K |
|
642
Kite Realty
KRG
$5.14B
| $4.14M | 0.02% |
211,883
-32,300
| -13% | -$583K |
|
|
MNR
643
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $4.12M | 0.02% |
284,200
| – | – |
|
644
Sun Life Financial
SLF
$44.6B
| $4.11M | 0.02% |
90,085
-20,200
| -18% | -$909K |
|
|
RP
645
DELISTED
RealPage, Inc.
RP
| $4.1M | 0.02% |
+76,273
| New | +$4.35M |
|
646
Insmed
INSM
$26.8B
| $4.08M | 0.02% |
+170,908
| New | +$3.48M |
|
647
Dow Inc
DOW
$21.7B
| $4.07M | 0.02% |
74,382
+2,253
| +3% | +$116K |
|
|
PS
648
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $4.07M | 0.02% |
236,512
+31,512
| +15% | +$536K |
|
649
Pilgrim's Pride
PPC
$7.06B
| $4.06M | 0.02% |
124,200
+1,500
| +1% | +$46.7K |
|
650
Brighthouse Financial
BHF
$2.81B
| $4.03M | 0.02% |
+102,600
| New | +$4.04M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.